Based on FMI’s most recent market research, the global mammalian transient protein expression market sales is expected to grow at an 8.5% CAGR from 2023 to 2033. The market is projected to be valued US$ 697.2 million in 2023. It is anticipated that the valuation will reach US$ 1,581.6 million by 2033.
The market for Mammalian Transient Protein Expression is likely to witness significant growth in terms of revenue. The mammalian cells for protein expression market are also expanding, which is a result of increased industry investment in research and development as well as advancements in technologies that enable more precise and effective protein creation. Nevertheless, the use of mammalian cells for protein expression as therapeutic agents is being made easier by the development of new delivery systems, such as nanotechnology and drug-delivery vehicles, and is anticipated to propel the growth of the mammalian cells for protein expression market in the near future.
Get a Sample Copy of the Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-12807
The growing market for Mammalian Transient Protein Expression includes a significant portion devoted to the expression of transitory proteins in mammals. Companies use this technology to create functional proteins, polypeptides, and other molecules.
Key Takeaways:
- The introduction of new delivery systems, such as nanotechnology and drug-delivery vehicles, is likely to be the significant driver of the market.
- The global Mammalian Transient Protein Expression is expected to hold a valuation of US$ 697.2 million in 2023.
- The global Mammalian Transient Protein Expression market is expected to surpass US$ 1,581.6 million by 2033.
- The Mammalian Transient Protein Expression market is likely to record a CAGR of 8.5% from 2023 to 2033.
- The biopharmaceutical companies segment recorded a CAGR of 9.8% from 2018 to 2022 and is expected to record a CAGR of 9.1% from 2023 to 2033.
- The Mammalian Transient Protein Expression market in China is likely to record a CAGR of 9.0% over the forecast period.
- The reagents and consumables segment recorded a CAGR of 10.6% from 2018 to 2022 and is expected to register a CAGR of 9.6% from 2023 to 2033.
Competitive Landscape
The key players operating in the Mammalian Transient Protein Expression market are investing in mergers and acquisitions to gain a significant market share. The manufacturers are also investing in research and development and are introducing innovative methods to boost production capacity. Product development and market expansion are significant aspects of the Mammalian Transient Protein Expression market. As a result, market participants are likely to have a better overall revenue share in the global Mammalian Transient Protein Expression market.
Recent Developments:
- In October 2020, Merck KgaA announced its expansion, which included the opening of a new membrane manufacturing facility in Darmstadt, Germany. Increasing the output of Millipore Express membranes was the objective.
- Thermo Fisher Scientific introduced the GMP-produced Gibco CTS TrueCut Cas9 Protein in April 2022.
Significant Key Players are:
- Thermofisher Scientific
- Merck KGaA
- Promega Corporation
- Lonza
- Agilent Technologies, Inc.
- Bio-Rad
- Qiagen
- Takara Bio
- HiMedia Laboratories.
- Mirus
- Sino Biological, Inc.
Key Segments:
By Product:
- Instruments
- Expression Vector
- Reagents & Consumables
- Cell Lines
- Chinese Hamster Ovary Cells (CHO)
- Human embryonic kidney 293 (HEK 293) cells
- Others
By Application:
- Bio-production
- Antibody Production
- Therapeutic protein production
- Functional Cell-Based Assays
- Academic Research
- Others
By End User:
- Contract Research Organization
- Biopharmaceutical Companies
- Academic & Research Institutes
Unlock exclusive insights with our expert analysts:
https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-12807
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube